N-acetyl cysteine ameliorates depression-induced cognitive deficits by restoring the volumes of hippocampal subfields and associated neurochemical changes
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Neurochemistry International
- Vol. 132, 104605
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Mental Health and Neuro Sciences
- Bengaluru and Indian Council of Medical Research (3/1/2/74/Neuro/2018-NCD-I)
- ICMR, New Delhi, India (45/04/2018-ANA-BMS)
- Department of Biotechnology
- Council of Scientific & Industrial Research
- Science and Engineering Research Board, Department of Science & Technology, Government of India (SERB-DST), New Delhi
- National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, India
This publication has 110 references indexed in Scilit:
- Cerebrospinal Fluid Metabolome in Mood Disorders-Remission State has a Unique Metabolic ProfileScientific Reports, 2012
- Repeated Stress Causes Cognitive Impairment by Suppressing Glutamate Receptor Expression and Function in Prefrontal CortexNeuron, 2012
- Chronic fluoxetine treatment in middle-aged rats induces changes in the expression of plasticity-related molecules and in neurogenesisBMC Neuroscience, 2012
- CA1 neurons in the human hippocampus are critical for autobiographical memory, mental time travel, and autonoetic consciousnessProceedings of the National Academy of Sciences, 2011
- Oxotremorine treatment restores hippocampal neurogenesis and ameliorates depression-like behaviour in chronically stressed ratsPsychopharmacology, 2011
- A complex interaction between glycine/NMDA receptors and serotonergic/noradrenergic antidepressants in the forced swim test in miceJournal of Neural Transmission, 2011
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA AntagonistsScience, 2010
- Functional interrelations between nucleus raphé dorsalis and nucleus raphé medianus: A dual probe microdialysis study of glutamate-stimulated serotonin releaseBrain Research Bulletin, 2009
- Targeting the glutamatergic system to develop novel, improved therapeutics for mood disordersNature Reviews Drug Discovery, 2008
- Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effectsProceedings of the National Academy of Sciences, 2006